Showing results (2351-2360 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|June 28, 2018
Methionine gamma lyase from Clostridium sporogenes increases the anticancer effect of doxorubicin in A549 cells and human cancer xenograftsV S Pokrovsky, N Yu Anisimova, D Zh Davydov, et al.
Investigational New Drugs|February 1, 1991
Relationship between glutathione levels and drug or radiation sensitivities in human gastric cancer cell lines in vitroS C Barranco, B Weintraub, K K MacLean, et al.
Investigational New Drugs|February 1, 1991
Phase II study of amonafide (nafidamide, NSC 308847) in advanced colorectal cancerP J O'Dwyer, A R Paul, G R Hudes, et al.
Investigational New Drugs|February 1, 1991
Cyclopentenyl cytosine: interspecies predictions based on rodent plasma and urine kineticsD S Zaharko, J A Kelley, J E Tomaszewski, et al.
Investigational New Drugs|January 20, 2010
Potent anti-tumor activity of a macrocycle-quinoxalinone class pan-Cdk inhibitor in vitro and in vivoHiroshi Hirai, Ikuko Takahashi-Suziki, Toshiyasu Shimomura, et al.
Investigational New Drugs|September 21, 2016
New water-soluble palladium(II) complexes of lidocaine and phenylcyanamide derivative ligands: cytotoxicity and cellular response mechanismsLeila Tabrizi, Hossein Chiniforoshan
Investigational New Drugs|September 2, 2016
Comparative effects of doxorubicin and a doxorubicin analog, 13-deoxy, 5-iminodoxorubicin (GPX-150), on human topoisomerase IIβ activity and cardiac function in a chronic rabbit modelNicole E Frank, Barry J Cusack, Todd T Talley, et al.
Investigational New Drugs|August 28, 2016
Sunitinib maintenance therapy after response to docetaxel in metastatic castration resistant prostate cancer (mCRPC)Sunil Parimi, Misha Eliasziw, Scott North, et al.
Investigational New Drugs|September 1, 1988
Phase I trial of adjuvant chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil (CEF) for stage II breast cancerS E Jones, R G Mennel, G N Peters, et al.
Investigational New Drugs|September 1, 1988
A phase II trial of oral 4'demethoxydaunorubicin (DMDR) in inoperable non small cell lung cancerP Presgrave, R Woods, R Kefford, et al.
Pageof 372